Lenalidomide/Tafasitamab Regimen

Preferred Label : Lenalidomide/Tafasitamab Regimen;

NCIt synonyms : Lenalidomide/Monjuvi; Lenalidomide Plus Tafasitamab; Tafasitamab Plus Lenalidomide; Tafasitamab-Lenalidomide; Tafasitamab/Lenalidomide; Tafasitamab/Lenalidomide Regimen; Lenalidomide/Tafasitamab; Lenalidomide-Tafasitamab; Tafasitamab-cxix/Lenalidomide; Lenalidomide/Tafasitamab-cxix;

NCIt related terms : Lenalidomide and Tafasitamab;

NCIt definition : A regimen consisting of lenalidomide and tafasitamab that can be used for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL).;

NCI Metathesaurus CUI : CL1407869;

Codes from synonyms : 14816;

Details

Origin ID

C173953;

UMLS CUI

C5420482;

Est indiqué pour
- Recurrent Diffuse Large B-Cell Lymphoma [NCIt concept]
- Refractory Diffuse Large B-Cell Lymphoma [NCIt concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Lenalidomide [NCIt concept]
- Tafasitamab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
- Single-agent Therapeutic Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients